Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC collaborates with UCB on bone overgrowth research
"It is an incredible opportunity to advance our understanding of this ultra-rare bone disease" - Dr Tim Dreyer.

The project will explore Sclerosteosis and Ankylosing Spondylitis.

The Royal Veterinary College (RVC) is collaborating with the biopharmaceutical company UCB to research diseases of excessive bone formation.

In a new multi-year research project, the organisations will investigate therapeutic options and mechanisms of disease progression in two severe bone diseases characterised by bone overgrowth - sclerosteosis, and the inflammatory condition ankylosing spondylitis.

Dr Scott Roberts, senior lecturer in translational skeletal research at the RVC, said: “I am excited to be working closely with UCB and RVC colleagues to investigate why pathological bone is formed in ankylosing spondylitis and how excessive bone formation can be controlled in sclerosteosis. 

“This research interaction will allow us to further our understanding of these specific diseases, with our accrued knowledge also likely to be applicable to other conditions of altered bone metabolism.”

Sclerosteosis is an ultra-rare genetic bone disease, in which patients experience widespread bone overgrowth as a result of the loss of sclerostin expression. The overgrowth of bone can result in severe, and even fatal, pressure on the brain due to increases in skull thickness. This can only be resolved temporarily through major surgery.

Ankylosing spondylitis patients also experience bone overgrowth, occurring most commonly in the spine. This overgrowth can lead to pain, bone fusion and deformity. The major change of structural tissue damage can result in permanent disability. 

Over the course of three years, the team of researchers led by Dr Scott Roberts, will test potential new therapeutic options in preclinical models for sclerosteosis. Whilst ankylosing spondylitis already has approved therapeutics, the team will be researching why this bone forms using specialised disease models via human stem cells. 

Dr Tim Dreyer, postdoctoral researcher and sclerosteosis patient, commented on the new collaboration: “As a patient myself, I am thrilled to be part of a collaboration that aims to potentially develop a therapeutic for Sclerosteosis. 

“It is an incredible opportunity to advance our understanding of this ultra-rare bone disease, whilst providing hope for a small group of patients and their families.”

Senior vice president and head of discovery science at UCB, Dr Alistair Henry, added: “We are delighted to partner with the RVC on this important project to better understand disease progression in these two conditions. 

“Although very different diseases, both conditions have a painful and progressive impact on those living with them and we hope this project may pave the way for treatment to improve people’s lives.”

 

Image (C) Royal Veterinary College

Become a member or log in to add this story to your CPD history

World Bee Day celebrations begin

News Story 1
 Today (20 May) marks the fifth annual World Bee Day, which raises awareness of the importance of bees and pollinators to people and the planet. Observed on the anniversary of pioneering Slovenian beekeeper Anton Jana's birthday, this year's celebration is themed: 'Bee Engaged: Celebrating the diversity of bees and beekeeping systems'.

Organisations and people celebrating the day will raise awareness of the accelerated decline in pollinator diversity, and highlight the importance of sustainable beekeeping systems and a wide variety of bees. Slovenia, the initiator of World Bee Day, will be focusing on teaching young people about the significance of pollinators. 

Click here for more...
News Shorts
Further avian flu cases confirmed

Three cases of highly pathogenic avian influenza (HPAI) H5N1 have been confirmed in recent days, bringing the total number of cases in England to 98.

On Thursday, the APHA confirmed two cases of HPAI H5N1 near Redgrave, Mid Suffolk and Market Weston, West Suffolk. A case H5N1 was also confirmed in poultry at a premises near Southwell, Newark and Sherwood, Nottinghamshire.

Protection and surveillance zones are in place around the affected premises. Further details are available at gov.uk